Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481049 · ClinicalTrials.gov registry record · NA
Individualizing Incentives for Alcohol in the Severely Mentally Ill
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 392
- Enrollment target
NCT03481049: Completed NA study, sponsored by Washington State University.
NCT03481049 is a NA study that has completed, run by Washington State University. The registered enrollment target is 392 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03481049, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 392 participants
- Enrollment target
Study Summary
The investigators will evaluate the efficacy of a 2 various contingency management (CM) interventions (High-Magnitude CM, Shaping CM) for treating heavy drinking among individuals with serious mental illness and alcohol dependence who are seen within the context of a community mental health center setting. Participants will be 400 adults diagnosed with serious mental illness and alcohol dependence and those who demonstrate heavy drinking during the first 4 weeks will be randomized to receive treatment conditions.
Primary Outcome
Proportion of uEtG negative samples during weeks 5-16 of treatment. (EtG \<150 ng/mL = EtG-negative)
Interventions
- BEHAVIORAL Usual CM
- BEHAVIORAL High-Magnitude CM
- BEHAVIORAL Shaping CM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2018-05-05 |
| Est. Completion | 2024-11-22 |
| Phase | NA |
What the finished NCT03481049 record still lists
NCT03481049 is an interventional study that assigns participants to a tested intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual CM is the first listed.
NCT03481049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03481049 about?
NCT03481049 is a clinical study titled "Individualizing Incentives for Alcohol in the Severely Mentally Ill". The investigators will evaluate the efficacy of a 2 various contingency management (CM) interventions (High-Magnitude CM, Shaping CM) for treating heavy drinking among individuals with serious mental illness and alcohol dependence who are seen within the context of a community mental health center s...
What is the current status of trial NCT03481049?
This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2018-05-05. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT03481049?
The interventions under investigation include: Usual CM (BEHAVIORAL), High-Magnitude CM (BEHAVIORAL), Shaping CM (BEHAVIORAL).
Who is sponsoring clinical trial NCT03481049?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03481049's enrollment target sits among peer trials
392 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI